Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
IDEXX Laboratories, Inc. is a global diagnostics and information technology company serving the veterinary, livestock, poultry, dairy, and water testing markets. The company operates primarily in the veterinary diagnostics, animal health, and water microbiology industries, providing testing instruments, consumables, reference laboratory services, and software solutions. IDEXX’s core revenue is driven by recurring consumables and reference laboratory testing associated with its installed base of diagnostic instruments.
The company’s primary business is organized around companion animal healthcare, which represents the majority of revenue, supplemented by water quality testing and food‑animal diagnostics. IDEXX serves veterinary clinics, animal health professionals, livestock producers, government agencies, and municipalities. The company is recognized for its integrated diagnostic ecosystem that combines in‑clinic instruments, laboratory services, and practice management software, creating high switching costs and strong customer retention. IDEXX was founded in 1983 by David Shaw and initially focused on livestock diagnostics before expanding into companion animal diagnostics, which became its dominant business as veterinary spending increased globally.
Business Operations
IDEXX operates through three reportable business segments: Companion Animal Group (CAG), Water, and Livestock, Poultry & Dairy (LPD). Companion Animal Group (CAG) generates the majority of revenue through in‑clinic diagnostic instruments, consumables, reference laboratory testing, and software solutions offered under businesses such as IDEXX Reference Laboratories and IDEXX VetLab. Revenue in this segment is largely recurring due to ongoing test usage tied to installed diagnostic equipment.
The Water segment, primarily operating through IDEXX Water Microbiology, provides testing solutions for the detection of microbial contaminants in water, serving municipal water utilities and private laboratories. The Livestock, Poultry & Dairy (LPD) segment offers diagnostic tests and services for production animals, including disease detection and food safety testing. IDEXX operates both domestically and internationally, with manufacturing, laboratory, and distribution facilities supporting sales in North America, Europe, Asia‑Pacific, and Latin America.
Strategic Position & Investments
IDEXX’s strategy focuses on expanding its diagnostic menu, increasing instrument placements, and deepening customer integration through data, software, and workflow solutions. The company invests heavily in research and development to enhance diagnostic accuracy, speed, and connectivity across its platforms. A key strategic advantage is IDEXX’s ability to bundle instruments, consumables, reference testing, and software into a unified offering for veterinary practices.
The company has pursued selective acquisitions to strengthen its software and data capabilities, most notably the acquisition of ezyVet, a cloud‑based veterinary practice management software provider, which expanded IDEXX’s digital and data analytics footprint. IDEXX continues to invest in emerging diagnostic technologies, including advanced immunoassays and cloud‑connected diagnostic systems, while maintaining a disciplined capital allocation approach focused on organic growth, targeted acquisitions, and share repurchases.
Geographic Footprint
IDEXX Laboratories is headquartered in Westbrook, Maine, and operates globally with a strong presence in North America, Europe, Asia‑Pacific, and Latin America. The United States represents the company’s largest single market, particularly within the companion animal segment, while international markets contribute a significant and growing portion of total revenue.
The company maintains reference laboratories, manufacturing facilities, and commercial operations across multiple continents, supporting localized service delivery and regulatory compliance. IDEXX’s international footprint enables it to benefit from rising global pet ownership, increasing veterinary care standards, and growing demand for water quality testing in both developed and emerging markets.
Leadership & Governance
IDEXX is led by an executive team with extensive experience in diagnostics, healthcare, and global operations. The leadership emphasizes long‑term value creation through innovation, disciplined execution, and customer‑centric product development, with a strategic vision centered on advancing animal health and public health through diagnostics and data integration.
Key executives include:
- Jay Mazelsky – President and Chief Executive Officer
- Eric Folkert – Chief Financial Officer
- Joseph C. Grove – Executive Vice President, Operations
- Michael W. Hill – Executive Vice President, Global Companion Animal Group
- Patrick Melby – Executive Vice President, Chief Commercial Officer
The company operates under a shareholder‑oriented governance framework, with oversight provided by an independent board of directors and reporting aligned with U.S. public company standards.